利用身高增速和轨迹判定1型糖尿病青少年青春期状态
本研究在123名1型糖尿病青少年中开发并验证了一种基于纵向线性生长(身高增速和生长曲线轨迹)的青春期状态评估方法。在985次研究访视中,22%的青春期状态基于身高增速和生长曲线轨迹判定,敏感性分析显示该方法与临床Tanner分期在87%的访视中一致。结论认为生长是青春期起始、状态和进展的可靠客观生物标志。
要点
- 基于身高增速和生长曲线轨迹的青春期状态判定与临床Tanner分期在87%的访视中一致。
- 在无法获得体格或实验室评估时,身高增速和生长轨迹可作为客观的青春期状态评估工具。
- 该方法适用于1型糖尿病青少年的临床管理,有助于评估青春期变化。
核心结论
- 基于身高增速和生长曲线轨迹的青春期状态评估方法实用、客观,与临床Tanner分期一致性达87%。
- 生长可作为青春期起始、状态和进展的可靠客观生物标志。
研究设计与样本
- 研究纳入123名1型糖尿病青少年,来自一家三级糖尿病中心为期2年的连续血糖监测研究。
- 通过分层方法判定访视时的青春期状态:优先使用临床Tanner分期或电子病历中的青春期成熟指标,其余访视基于身高增速和生长曲线轨迹独立评估。
- 采用敏感性分析验证青春期状态判定的有效性。
主要发现
- 样本中女性占50%,白人占95%,平均年龄12.7±2.7岁,糖尿病病程6.0±3.6年,HbA1c为7.9±0.8%。
- 共985次研究访视,其中50%的青春期状态基于临床Tanner分期,29%基于额外病历回顾,22%基于身高增速和生长曲线轨迹评估。
- 敏感性分析中,基于身高增速和生长曲线轨迹的青春期状态判定与临床Tanner分期在87%的访视中一致。
临床怎么用
- 在无法进行体格或实验室青春期评估时,可利用身高增速和生长曲线轨迹客观判定1型糖尿病青少年的青春期状态。
- 该方法有助于临床管理中的青春期变化评估,减少对昂贵或不实用评估的依赖。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Assessment of pubertal change is important for the management of chronic pediatric diseases, such as type 1 diabetes. Physical and/or laboratory assessments of pubertal status are often unavailable, impractical, or costly. OBJECTIVE: To develop and validate a practical and objective method to assess pubertal status using longitudinal linear growth in youths with type 1 diabetes. DESIGN, PARTICIPANTS, AND OUTCOME MEASUREMENTS: Participants (n = 123) were part of a 2-year study assessing continuous glucose monitoring in youths with type 1 diabetes at a tertiary diabetes center. Pubertal status at visits was assigned by a tiered approach using clinical Tanner staging or indicators of pubertal maturation from the electronic medical record when available. For other visits, independent evaluations of height velocities and growth chart trajectories provided data for pubertal status assignments. Sensitivity analysis confirmed the validity of the pubertal status assignments. RESULTS: The sample (50% female, 95% white) had a mean ± SD age of 12.7 ± 2.7 years, diabetes duration of 6.0 ± 3.6 years, and hemoglobin A1c of 7.9 ± 0.8%. Of 985 study visits, 50% received a pubertal status assignment based on clinical Tanner staging, 29% on additional medical record review, and 22% on an evaluation of height velocity and growth chart trajectory. For the sensitivity analysis, pubertal status assignments based on height velocity and growth chart trajectory matched clinical Tanner staging in 87% of visits. CONCLUSIONS: Our practical and objective method to assess pubertal status based on height velocity and growth chart trajectory highlights growth as a reliable and objective bioassay for pubertal onset, status, and progression.
引用
- Zhu J, Volkening LK, Laffel LM, et al. Determination of Pubertal Status in Youths With Type 1 Diabetes Using Height Velocity and Trajectories. J Clin Endocrinol Metab. 2019. PMID: 30346541. doi:10.1210/jc.2018-01737
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。